GIS:NYSEGeneral Mills, Inc. Analysis
Data as of 2026-03-10 - not real-time
$42.74
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
GIS trades at $42.74, just above its 20‑day SMA of $45.35 and well below the 200‑day SMA of $48.61, signaling a bearish price environment. The 14‑day RSI sits at 35, indicating modest oversold pressure but not yet a clear reversal. MACD is in bearish territory with the line below the signal and a negative histogram. Daily volume has been trending down, confirming waning buying interest. The stock is hovering near its technical support at $42.46, with the next resistance anchored around $49.59.
On the fundamentals side, revenue fell 7.2% YoY to $18.8 B, while operating and profit margins remain solid at 17.9% and 13.5% respectively. A forward PE of 12.3 and a trailing PE of 9.2 place the stock in deep value territory relative to the market. The dividend yield of 5.6% and a payout ratio of 52% are backed by robust free cash flow of $2.48 B, suggesting sustainability. However, the balance sheet is leveraged, with a debt‑to‑equity of 147% and total debt exceeding $13.7 B. The DCF‑derived fair value of $39.74 is below the current price, implying a modest overvaluation of roughly 8%, yet the upside/downside metric shows a 12.7% upside potential if the stock reverts toward its fair value. Recent news confirms a downward revision of fiscal 2026 guidance amid weak consumer sentiment, adding pressure on the near‑term price. Given the combination of bearish technicals, valuation tension, and a strong dividend, investors should consider a cautious stance, using the dividend yield as a defensive buffer while monitoring for a potential price correction toward support.
On the fundamentals side, revenue fell 7.2% YoY to $18.8 B, while operating and profit margins remain solid at 17.9% and 13.5% respectively. A forward PE of 12.3 and a trailing PE of 9.2 place the stock in deep value territory relative to the market. The dividend yield of 5.6% and a payout ratio of 52% are backed by robust free cash flow of $2.48 B, suggesting sustainability. However, the balance sheet is leveraged, with a debt‑to‑equity of 147% and total debt exceeding $13.7 B. The DCF‑derived fair value of $39.74 is below the current price, implying a modest overvaluation of roughly 8%, yet the upside/downside metric shows a 12.7% upside potential if the stock reverts toward its fair value. Recent news confirms a downward revision of fiscal 2026 guidance amid weak consumer sentiment, adding pressure on the near‑term price. Given the combination of bearish technicals, valuation tension, and a strong dividend, investors should consider a cautious stance, using the dividend yield as a defensive buffer while monitoring for a potential price correction toward support.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical indicators (MACD, SMA crossover, RSI)
- Recent guidance cut and weak consumer sentiment
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Attractive dividend yield with sustainable payout
- Value-oriented valuation metrics (low PE, price to book)
- Potential mean‑reversion toward technical support
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong brand portfolio and cash flow generation
- Historically defensive consumer‑staples sector
- Long‑term dividend growth and low systematic beta
Key Metrics & Analysis
Financial Health
Revenue Growth-7.20%
Profit Margin13.51%
P/E Ratio9.2
ROE27.17%
ROA5.68%
Debt/Equity147.23
P/B Ratio2.4
Op. Cash Flow$2.4B
Free Cash Flow$2.5B
Technical Analysis
TrendBearish
RSI35.2
Support$42.46
Resistance$49.59
MA 20$45.35
MA 50$45.40
MA 200$48.61
MACDBearish
VolumeDecreasing
Fear & Greed Index78.73
Valuation
Fair Value$39.74
Target Price$48.16
Upside/Downside12.69%
GradeFair
TypeValue
Dividend Yield5.62%
Risk Assessment
Beta0.07
Volatility32.66%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.